SNDX Price / Book | Syndax Pharmaceuticals, Inc.

Syndax Pharmaceuticals, Inc. (SNDX) Price / Book

2026-09-03: Price/Book Ratio 122.36.
2026-06-30: Price/Book Ratio 129.07.
2026-03-31: Price/Book Ratio 49.69.
2025-12-31: Price/Book Ratio 28.41.

Historical market capitalization divided by filed shareholder equity.

Available history: 2016-03-31 to 2026-09-03
Data captured: 2026-09-04

Historical Price/Book Ratio

Date	Price/Book Ratio
2026-09-03	122.36
2026-06-30	129.07
2026-03-31	49.69
2025-12-31	28.41
2025-09-30	11.58
2025-06-30	5.12
2025-03-31	4.92
2024-12-31	3.93
2024-09-30	4.5
2024-06-30	4.02
2024-03-31	4.11
2023-12-31	3.31
2023-09-30	2.82
2023-06-30	3.63
2023-03-31	3.32
2022-12-31	3.71
2022-09-30	4.27
2022-06-30	3
2022-03-31	2.55
2021-12-31	2.95
2021-09-30	4.69
2021-06-30	3.89
2021-03-31	4.73
2020-12-31	4.22
2020-09-30	4.34
2020-06-30	3.87
2020-03-31	6.2
2019-12-31	7.54
2019-09-30	4.6
2019-06-30	4.57
2019-03-31	2.07
2018-12-31	2.08
2018-09-30	3.02
2018-06-30	2.27
2018-03-31	4.04
2017-12-31	2.05
2017-09-30	2.7
2017-06-30	2.84
2017-03-31	3.45
2016-12-31	1.55
2016-09-30	2.94
2016-06-30	1.65
2016-03-31	2.08

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Rapport Therapeutics, Inc. (RAPP)	United States	$1.623B	-14.56
Stoke Therapeutics, Inc. (STOK)	United States	$1.630B	-9.82
Xeris Biopharma Holdings, Inc. (XERS)	United States	$1.632B	-80.10
Kailera Therapeutics, Inc. (KLRA)	United States	$1.552B
ANAPTYSBIO, INC (ANAB)	United States	$1.546B	-60.20
Eton Pharmaceuticals, Inc. (ETON)	United States	$1.701B	80.74
Innoviva, Inc. (INVA)	United States	$1.493B	4.62
ArriVent BioPharma, Inc. (AVBP)	United States	$1.485B	-10.25
Ultragenyx Pharmaceutical Inc. (RARE)	United States	$1.456B	-5.62
OMEROS CORP (OMER)	United States	$1.456B	5.50